How To/Research Funding/York/Researching Type 1 Diabetes
All you need is here http://letsenddiabetes.jdrftype1.com
York, city, seat (1749) of York county, southeastern Pennsylvania, U.S., on Codorus Creek, 28 miles (45 km) southeast of Harrisburg. It is the focus of a metropolitan district that includes the boroughs of North York and West York and a number of townships. York was laid out (1741) in Springettsbury Manor, a tract owned by Springett Penn, William Penn’s grandson, and was named for York, England. In 1777 the Continental Congress left Philadelphia at the British approach and, after holding a one-day session in Lancaster, moved to York and made it the national capital (September 30, 1777–June 27, 1778). In the old county courthouse (built 1754–56, demolished 1849), Congress passed the Articles of Confederation, received the news of General John Burgoyne’s surrender at Saratoga, New York, issued the first national thanksgiving proclamation, and received word from Benjamin Franklin in Paris that France would aid the nascent United States. It was in York that the Conway Cabal, led by Thomas Conway to deprive George Washington of command of the army, was frustrated by the Marquis de Lafayette’s toast to Washington in General Gates’s House (c. 1751; restored). York was also the site where a large sum in silver (perhaps $600,000), lent by France, was brought in 1778, and where $10,000,000 in Continental money was issued from Benjamin Franklin’s printing press. During the American Civil War, Confederate troops entered the town (June 28, 1863), forcing the retreat of a small Union force. The economy is well diversified, based on agriculture, manufacturing, and distribution. Manufactures include refrigerating and ordnance equipment, motorcycles, and paper. York College of Pennsylvania was founded in 1787 and the York campus of Pennsylvania State University (Penn State York) in 1926. York is noted for its farmers’ markets. Inc. borough, 1787; city, 1887. Pop. Full list of Media Credits http://broadcaster.beazil.net/public/credits/youtube/videos/43275 While insulin injections or infusion allow a person with T1D to stay alive, they do not cure the disease, nor do they necessarily prevent the possibility of the disease’s serious effects, which may include: kidney failure, blindness, nerve damage, amputations, heart attack, stroke, and pregnancy complications. Although type 1 diabetes is a serious and difficult disease, treatment options are improving all the time, and people with T1D can lead full and active lives. JDRF is driving research to improve the technology people with T1D use to monitor blood sugar levels and deliver the proper doses of insulin, as well as research that will ultimately deliver a cure. Diagnosing Diabetes:
– A1C Test – measures your average blood glucose for the past 2 to 3 months. If the score is equal to or greater than 6.5%, diabetes is present. Health Care & Social Assistance sector comprises firms providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with providing medical care exclusively, continuing with those providing health care and social assistance and finally finishing with only social assistance. The services provided in this sector are delivered by trained health practitioners and social workers with requisite experience. JDRF is the only organization with a strategic research plan to end T1D. Our strategies include: Artificial Pancreas Systems Artificial pancreas systems will eliminate blood glucose testing and carb counting by totally automating insulin dosing, initially preventing dangerous low blood sugars and eventually ensuring ideal glucose control. Complications JDRF’s complications research is leading to therapies to treat and even reverse some of the debilitating, costly, and life-threatening complications caused by T1D. Encapsulation JDRF’s encapsulation research will restore insulin independence for 18 months to two years
by implanting newly created beta cells into a protective capsule, which eliminates the need for toxic immune suppression therapies. JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every.